Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery
2007
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
Parenteral Anticoagulants
2012 Standout
Methods for evaluation of platelet function
2009 StandoutNobel
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
2002 Standout
Prognostic Factors in Non-small Cell Lung Cancer
2002
Aprotinin counterbalances an increased risk of peri-operative haemorrhage in CABG patients pre-treated with Aspirin
1998
Aprotinin Versus Lysine Analogues: The Debate Continues
1998
Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting
2003
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
2000 Standout
Aprotinin and tranexamic acid for high transfusion risk cardiac surgery
2000
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2003 Standout
The 2004 World Health Organization classification of lung tumors
2005 Standout
Pathology of Drug-Eluting Stents in Humans
2006 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
Carcinosarcomas of the Lung
1999
High-Dose ϵ-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary Operations
1998
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
1994 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose Regimens
1996
Obesity and inflammation: the linking mechanism and the complications
2016 Standout
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
2002 Standout
Global epidemiology and outcomes of acute kidney injury
2018 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Photopolymerizable hydrogels for tissue engineering applications
2002 Standout
Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass
2005
Endovascular stents: Preliminary clinical results and future developments
1993
Early clinical experience with the implantation of a novel synthetic coronary stent graft
1999
Experience with repair of congenital heart defects using adjunctive endovascular devices
1995
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
2013 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
The Risk Associated with Aprotinin in Cardiac Surgery
2006
Serial angiographic follow-up after palmaz-schatz stent implantation: Comparison with conventional balloon angioplasty
1993
Matching based on quantitative coronary angiography as a surrogate for randomized studies: Comparison between stent implantation and balloon angioplasty of native coronary artery lesions
1993
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Adverse effects of methods for minimizing perioperative allogeneic transfusion: A critical review of the literature
1998
Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis
2008
Adenovirus-Mediated Transfer of a Minigene Expressing Multiple Isoforms of VEGF Is More Effective at Inducing Angiogenesis Than Comparable Vectors Expressing Individual VEGF cDNAs
2004
Subacute occlusion, bleeding complications, hospital stay and restenosis after Palmaz-Schatz coronary stenting under a new antithrombotic regimen
1996
Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin
1999
The creation of an antithrombotic surface by apyrase immobilization
2010 StandoutNobel
Coronary-Artery Stenting Compared with Balloon Angioplasty for Restenosis after Initial Balloon Angioplasty
1998
Angiographic and intravascular ultrasound predictors of in-stent restenosis
1998
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
1999
Subacute Stent Thrombosis in the Era of Intravascular Ultrasound-Guided Coronary Stenting Without Anticoagulation: Frequency, Predictors and Clinical Outcome
1997
Long-Term Treatment with a Platelet Glycoprotein-Receptor Antagonist after Percutaneous Coronary Revascularization
2000
A TALE nuclease architecture for efficient genome editing
2010 Standout
Prevention and Treatment of Major Blood Loss
2007
Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations
1998
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Recent developments in stainless steels
2009 Standout
Safety and Efficacy of Ticlopidine for Only 2 Weeks After Successful Intracoronary Stent Placement
1999
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
1998
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
2005 Standout
Characterization of the thrombogenic potential of surface oxides on stainless steel for implant purposes
2003
Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results.
2005
Ultrasound guidance of Palmaz-Schatz intracoronary stenting with a combined intravascular ultrasound balloon catheter.
1994
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
2004 Standout
Time course of restenosis during the first year after emergency coronary stenting.
1993
The Effect of Dietary ω-3 Fatty Acids on Coronary Atherosclerosis
1999 Standout
Acute Kidney Injury and Chronic Kidney Disease After Cardiac Surgery
2008
Randomized Evaluation of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation in High-Risk Patients
1998
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Interventions for protecting renal function in the perioperative period
2013
Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis
1998
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty).
1993
Polymeric Endoluminal Paving: A Family of Evolving Methods for Extending Endoluminal Therapeutics Beyond Stenting
1994
Clinical End Points in Coronary Stent Trials
2007 Standout
Stent Thrombosis in the Modern Era
2001
The Antiaggregating and Antithrombotic Activity of Clopidogrel Is Potentiated by Aspirin in Several Experimental Models in the Rabbit
1998
Predictors of Subacute Stent Thrombosis
2003
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer
2001
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Patterns and Mechanisms of In-Stent Restenosis
1996
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of U Straub being referenced
Pulmonary carcinosarcoma: diagnostic problems and determinants of the prognosis
1996
Celite and Kaolin Produce Differing Activated Clotting Times during Cardiopulmonary Bypass under Aprotinin Therapy
1994
Results of intracoronary stents for management of coronary dissection after balloon angioplasty
1991
Simultaneous surgical revascularization and angiogenic gene therapy in diffuse coronary artery disease
2001
Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents
1993
Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting
1995
Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer
2000
Short and long term results after intracoronary stenting in human coronary arteries: monocentre experience with the balloon-expandable Palmaz-Schatz stent.
1991